126 related articles for article (PubMed ID: 6127208)
21. Immunoprecipitation of TSH-TSH receptor complexes.
Parkes AB; Kajita Y; Buckland PR; Howells RD; Rickards CR; Creagh FM; Rees Smith B
Clin Endocrinol (Oxf); 1985 Apr; 22(4):511-20. PubMed ID: 2985304
[TBL] [Abstract][Full Text] [Related]
22. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis.
Endo K; Kasagi K; Konishi J; Ikekubo K; Okuno T; Takeda Y; Mori T; Torizuka K
J Clin Endocrinol Metab; 1978 May; 46(5):734-9. PubMed ID: 45421
[TBL] [Abstract][Full Text] [Related]
23. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins.
Heyma P; Harrison LC
J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581
[TBL] [Abstract][Full Text] [Related]
24. The species specificity of TSH receptor binding antibodies as measured by radioreceptor study.
Strakosch CR; Joyner D; Manley SW; Wall JR
Clin Endocrinol (Oxf); 1982 Aug; 17(2):173-9. PubMed ID: 6127179
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
Tamaki H; Amino N; Iwatani Y; Tachi J; Kimura M; Mitsuda N; Ichihara K; Tanizawa O; Miyai K
Clin Endocrinol (Oxf); 1989 May; 30(5):493-503. PubMed ID: 2575017
[TBL] [Abstract][Full Text] [Related]
26. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
Gerding MN; van der Meer JW; Broenink M; Bakker O; Wiersinga WM; Prummel MF
Clin Endocrinol (Oxf); 2000 Mar; 52(3):267-71. PubMed ID: 10718823
[TBL] [Abstract][Full Text] [Related]
27. TSH receptor binding and thyroid stimulation by sera from patients with Graves' disease.
Ginsberg J; Shewring G; Smith BR
Clin Endocrinol (Oxf); 1983 Sep; 19(3):305-11. PubMed ID: 6138173
[TBL] [Abstract][Full Text] [Related]
28. [Studies on the radioreceptor assay of TSH: the properties of TSH-binding inhibitor immunoglobulins (TBII) in patients with Hashimoto's thyroiditis (author's transl)].
Endo K
Nihon Naibunpi Gakkai Zasshi; 1979 Oct; 55(10):1275-85. PubMed ID: 228999
[TBL] [Abstract][Full Text] [Related]
29. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of anti-TSH antibody in sera from patients with Graves' disease and other thyroid disorders.
Akamizu T; Mori T; Imura H; Noh J; Hamada N; Ito K; Koizumi Y; Yamada T; Fujihira T; Eto S
J Endocrinol Invest; 1989; 12(7):483-8. PubMed ID: 2571629
[TBL] [Abstract][Full Text] [Related]
31. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
[TBL] [Abstract][Full Text] [Related]
32. Anti-TSH receptor antibodies in Graves' disease modulate the kinetic behaviour of autologous thyroid TSH receptors. Evidence of the IgG-induced cross-linkage of autologous TSH receptors.
de Bruin TW; van der Heide D
Acta Endocrinol (Copenh); 1984 Mar; 105(3):330-40. PubMed ID: 6322495
[TBL] [Abstract][Full Text] [Related]
33. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
[TBL] [Abstract][Full Text] [Related]
34. Interaction between thyroid-stimulating immunoglobulins and thyrotropin receptors in fat cell membranes.
Kishihara M; Nakao Y; Baba Y; Matsukura S; Kuma K; Fujita T
J Clin Endocrinol Metab; 1979 Nov; 49(5):706-11. PubMed ID: 226558
[TBL] [Abstract][Full Text] [Related]
35. [Studies on the thyrotropin receptor and adenylate cyclase activity in various thyroid diseases: I. The properties of TSH receptor and adenylate cyclase in Graves' thyroid and retro-orbital adipose tissues (author's transl)].
Abe Y
Nihon Naibunpi Gakkai Zasshi; 1980 May; 56(5):739-53. PubMed ID: 6248386
[TBL] [Abstract][Full Text] [Related]
36. Evidence against the importance in the disease process of antibodies to bovine thyroid-stimulating hormone found in some patients with Graves' disease.
Noh J; Hamada N; Saito H; Oyanagi H; Ishikawa N; Momotani N; Ito K; Morii H
J Clin Endocrinol Metab; 1989 Jan; 68(1):107-13. PubMed ID: 2909548
[TBL] [Abstract][Full Text] [Related]
37. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay.
Maugendre D; Massart C
Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931
[TBL] [Abstract][Full Text] [Related]
38. Antithyrotropin antibodies in the sera of Graves' disease patients.
Raines KB; Baker JR; Lukes YG; Wartofsky L; Burman KD
J Clin Endocrinol Metab; 1985 Aug; 61(2):217-22. PubMed ID: 2989314
[TBL] [Abstract][Full Text] [Related]
39. Interference with thyrotropin receptor antibody determination by a spuriously occurring anti-bovine TSH antibody.
Iitaka M; Tanikawa T; Sakatsume Y; Yanagisawa M; Hara Y; Ishii J
Acta Endocrinol (Copenh); 1986 Jun; 112(2):197-203. PubMed ID: 2874680
[TBL] [Abstract][Full Text] [Related]
40. Thyrotropin receptor non-mediated thyroid stimulating immunoglobulin in Graves' disease.
Endo T; Haraguchi K; Ohmori M; Ikeda M; Ohta K; Onaya T
Biochem Biophys Res Commun; 1991 Sep; 179(3):1543-7. PubMed ID: 1656957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]